ARCHIVES

Richard Pazdur’s Comments to ODAC

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

NCI Approved Clinical Trials

May 28, 2010

HHS Proposes Stronger Health Warnings On Cigarette Packages, Ads

November 12, 2010

The March: Research Task Force Calls For $10 Billion NCI Budget In 5 Years

October 2, 1998

IOM Report Urges DOD, VA, Congress To End Tobacco Use In Military.

July 10, 2009

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994